Literature DB >> 10373569

Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.

C Cenciarelli1, F De Santa, P L Puri, E Mattei, L Ricci, F Bucci, A Felsani, M Caruso.   

Abstract

During the terminal differentiation of skeletal myoblasts, the activities of myogenic factors regulate not only tissue-specific gene expressions but also the exit from the cell cycle. The induction of cell cycle inhibitors such as p21 and pRb has been shown to play a prominent role in the growth arrest of differentiating myoblasts. Here we report that, at the onset of differentiation, activation by MyoD of the Rb, p21, and cyclin D3 genes occurs in the absence of new protein synthesis and with the requirement of the p300 transcriptional coactivator. In differentiated myocytes, cyclin D3 also becomes stabilized and is found nearly totally complexed with unphosphorylated pRb. The detection of complexes containing cyclin D3, cdk4, p21, and PCNA suggests that cdk4, along with PCNA, may get sequestered into high-order structures held together by pRb and cyclin D3. Cyclin D3 up-regulation and stabilization is inhibited by adenovirus E1A, and this correlates with the ability of E1A to promote pRb phosphorylation; conversely, the overexpression of cyclin D3 in differentiated myotubes counteracts the E1A-mediated reactivation of DNA synthesis. These results indicate that cyclin D3 critically contributes to the irreversible exit of differentiating myoblasts from the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10373569      PMCID: PMC84363          DOI: 10.1128/MCB.19.7.5203

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  105 in total

1.  Expression of the positive regulator of cell cycle progression, cyclin D3, is induced during differentiation of myoblasts into quiescent myotubes.

Authors:  M Kiess; R M Gill; P A Hamel
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

2.  Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

Authors:  O Halevy; B G Novitch; D B Spicer; S X Skapek; J Rhee; G J Hannon; D Beach; A B Lassar
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

3.  Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.

Authors:  S X Skapek; J Rhee; D B Spicer; A B Lassar
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

Review 4.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

5.  Tissue-specific gene activation by MyoD: determination of specificity by cis-acting repression elements.

Authors:  H Weintraub; T Genetta; T Kadesch
Journal:  Genes Dev       Date:  1994-09-15       Impact factor: 11.361

6.  A family of transcriptional adaptor proteins targeted by the E1A oncoprotein.

Authors:  Z Arany; D Newsome; E Oldread; D M Livingston; R Eckner
Journal:  Nature       Date:  1995-03-02       Impact factor: 49.962

7.  Regulation of cyclins and p34CDC2 expression during terminal differentiation of C2C12 myocytes.

Authors:  J Wang; B Nadal-Ginard
Journal:  Biochem Biophys Res Commun       Date:  1995-01-05       Impact factor: 3.575

8.  Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts.

Authors:  M Pagano; A M Theodoras; S W Tam; G F Draetta
Journal:  Genes Dev       Date:  1994-07-15       Impact factor: 11.361

9.  p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.

Authors:  S B Parker; G Eichele; P Zhang; A Rawls; A T Sands; A Bradley; E N Olson; J W Harper; S J Elledge
Journal:  Science       Date:  1995-02-17       Impact factor: 47.728

10.  MyoD induces retinoblastoma gene expression during myogenic differentiation.

Authors:  F Martelli; C Cenciarelli; G Santarelli; B Polikar; A Felsani; M Caruso
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

View more
  45 in total

Review 1.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

2.  Cyclin D-cdk4 activity modulates the subnuclear localization and interaction of MEF2 with SRC-family coactivators during skeletal muscle differentiation.

Authors:  Jean-Bernard Lazaro; Peter J Bailey; Andrew B Lassar
Journal:  Genes Dev       Date:  2002-07-15       Impact factor: 11.361

3.  Expression of a mutant lamin A that causes Emery-Dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts.

Authors:  Catherine Favreau; Dominique Higuet; Jean-Claude Courvalin; Brigitte Buendia
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

4.  Requirement for down-regulation of the CCAAT-binding activity of the NF-Y transcription factor during skeletal muscle differentiation.

Authors:  Aymone Gurtner; Isabella Manni; Paola Fuschi; Roberto Mantovani; Fiorella Guadagni; Ada Sacchi; Giulia Piaggio
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

5.  Rb1cc1 is critical for myoblast differentiation through Rb1 regulation.

Authors:  Ryosuke Watanabe; Tokuhiro Chano; Hirokazu Inoue; Takahiro Isono; Osamu Koiwai; Hidetoshi Okabe
Journal:  Virchows Arch       Date:  2005-06-21       Impact factor: 4.064

Review 6.  Defining the transcriptional signature of skeletal muscle stem cells.

Authors:  Z Yablonka-Reuveni; K Day; A Vine; G Shefer
Journal:  J Anim Sci       Date:  2007-09-18       Impact factor: 3.159

7.  Regulation of apoptotic and growth inhibitory activities of C/EBPalpha in different cell lines.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Nikolai A Timchenko
Journal:  Exp Cell Res       Date:  2008-02-13       Impact factor: 3.905

Review 8.  Reflections on lineage potential of skeletal muscle satellite cells: do they sometimes go MAD?

Authors:  Gabi Shefer; Zipora Yablonka-Reuveni
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2007       Impact factor: 1.807

9.  Cyclin D3 maintains growth-inhibitory activity of C/EBPalpha by stabilizing C/EBPalpha-cdk2 and C/EBPalpha-Brm complexes.

Authors:  Guo-Li Wang; Xiurong Shi; Elizabeth Salisbury; Yuxiang Sun; Jeffrey H Albrecht; Roy G Smith; Nikolai A Timchenko
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

10.  The core binding factor CBF negatively regulates skeletal muscle terminal differentiation.

Authors:  Ophélie Philipot; Véronique Joliot; Ouardia Ait-Mohamed; Céline Pellentz; Philippe Robin; Lauriane Fritsch; Slimane Ait-Si-Ali
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.